Research On The Impact Of R&D Investment On Enterprise Performance Of Biomedical Enterprises

In recent years,under the background of the new era,innovation has gradually become the focus of national attention.With the intensification of industry competition,the impact of enterprise R&D activities on enterprise performance has gradually increased,which has been widely concerned by enterprises.At the same time,affected by national policies and industry demand,the impact of R&D investment on enterprise performance is also different.As a national emerging industry,the development of biomedical industry is closely related to people’s life and health,and the social demand is large,but it needs large R&D investment in production to ensure the orderly progress of R&D activities.Therefore,taking the biomedical industry as the research object,aiming at the relationship between enterprise R&D investment and enterprise performance is of positive significance.This thesis takes the listed companies in the biomedical industry in Shanghai and Shenzhen A-share market as the research object,selects the specific data from 2015 to 2020,takes the R&D capital investment and R&D personnel investment as indicators,and makes descriptive statistics and trend analysis on the specific data,Finally,using multiple linear regression analysis as the main research tool,this thesis makes a correlation analysis on the relevant data,and makes a data analysis and Empirical Analysis on the impact of enterprise R&D investment on enterprise performance under the regulation of different ownership structure.Firstly,by summarizing the literature on R&D investment,influencing factors of enterprise performance and ownership structure,this thesis defines the relevant concepts of biomedical industry,enterprise performance and R&D investment,and analyzes and describes the relationship between R&D investment and enterprise performance in combination with relevant theories such as technological innovation and core competitiveness.Secondly,through the overall analysis of the biomedical industry,combined with the theoretical analysis and description of R&D investment and enterprise performance,combined with the previous theoretical research basis and problems,this thesis puts forward the assumptions of this thesis;Enterprise performance as a dependent variable,R&D capital investment and R&D personnel investment as independent variables,combined with other influencing factors as adjustment variables,and enterprise scale,enterprise growth and asset liability ratio are included in the control variables to build a multiple regression model to analyze the relevant factors in detail.Thirdly,according to the empirical analysis model and relevant industry data,this thesis analyzes the performance of biomedical listed companies,and carries out multiple regression analysis on various factors through descriptive statistics and correlation analysis.According to the results,the sample data show that the current R&D capital investment of China’s pharmaceutical listed companies is negatively correlated with enterprise performance at a significant level of 10%,there is no correlation between the current R&D personnel investment and enterprise performance,and there is a lag between R&D capital investment and R&D personnel investment for a certain period of time;Ownership concentration can effectively and positively regulate the relationship between R&D investment and performance;The nature of equity and the degree of equity checks and balances have a negative regulatory effect on the relationship between R&D investment and enterprise performance.Finally,from the aspects of strengthening R&D,strengthening cooperation with scientific research institutions,improving internal operation efficiency,implementing international development path,strengthening the reform of state-owned enterprises,strengthening internal governance mechanism and standardizing R&D expenditure information disclosure,this thesis puts forward countermeasures and suggestions for biomedical enterprises to reasonably carry out R&D investment.By studying the relationship between R&D investment and enterprise performance of biomedical enterprises,this thesis hopes to provide reference for the rational allocation of R&D investment of biomedical enterprises.